Skip to content

The Effect of Neuromuscular Electrical Stimulation (NMES) on the Renal Function and Renal Blood Flow

The Effect of Neuromuscular Electrical Stimulation (NMES) on the Renal Function and Renal Blood Flow for Patients With Pregnancy Related- Acute Kidney Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04580329
Acronym
NMES
Enrollment
60
Registered
2020-10-08
Start date
2020-10-15
Completion date
2020-11-30
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Injury

Keywords

neuromuscular electrical stimulation, renal function, renal blood flow, Acute kidney injury

Brief summary

A randomized prospective controlled study aims to evaluate the effect of neuromuscular electrical stimulation on the renal function and renal blood flow of post partum women with acute kidney injury.

Interventions

PROCEDUREneuromuscular electrical stimulation (NMES) in addition to routine hospital care

Patients in the NMES group will receive NMES sessions as the electrodes will be placed around the bilateral femoral quadriceps muscles and at the site of renal arteries. NMES(\>100 Hz, 50-80 μ sec) will be performed for 55 min including 5 minutes for warm up and 5 minutes for recovery . The intensity of electrical stimulation will be adjusted to suit the comfort level of each individual patient without producing discomfort or pain.

PROCEDUREroutine hospital care without NMES

routine hospital care include all the routine intervention done for post partum women with AKI including fluid resuscitation, diuretics, hemodialysis

Sponsors

Ahmed talaat ahmed aly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 or old and hemodynamically stable. * Post-partum women who developed AKI.

Exclusion criteria

* Pregnant women . * Patients who required any emergency or elective surgery during the study; those who presented acute heart or lung disease, skin rashes, tumors, infections, diabetes mellitus or hypoesthesia in the region that the neuromuscular electrical stimulation would be applied. * Patients with a Pacemaker. * Epileptic Patients. * Patients with recent effects of stroke (less than 3 months). * Uncontrolled hypertension (systolic blood pressure \> 230 mm Hg and diastolic blood pressure \> 120 mm Hg).

Design outcomes

Primary

MeasureTime frameDescription
renal function changefor 7 daysserum creatinine level will be assessed and it will show improvement
renal blood flow changefor 7 daysurine output will be assessed and it will show improvement

Countries

Egypt

Contacts

Primary ContactAhmed T Ahmed, A professor
talaat83@aun.edu.eg01062716629
Backup ContactAmal A Mohamed
amalabdelnasser28@gmail.com0102 175 9992

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026